Skip to search formSkip to main contentSkip to account menu

Encapsulating Peritoneal Sclerosis

Known as: Peritoneal Scleroses, Encapsulating, Peritoneal Sclerosis, Encapsulating, Scleroses, Encapsulating Peritoneal 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
BACKGROUND Acetate-free dialysis (AFD) improves haemodynamic stability during dialysis, compared with standard haemodialysis (HD… 
2010
2010
AIMS Although peritoneal dialysis (PD) is recommended as the first-line treatment for end-stage renal disease, limitations exist… 
2009
2009
Background: Increased local levels of fibrogenic growth hormones contribute substantially to the process of encapsulating… 
2009
2009
In Japan, only about 3% of all patients with end-stage renal disease are maintained by continuous ambulatory peritoneal dialysis… 
2008
2008
BACKGROUND Ultrafiltration failure associated with peritoneal fibrosis can lead patients to discontinue continuous ambulatory… 
Review
2007
Review
2007
A long lasting peritoneal dialysis (PD) leads to a special disease, so-called encapsulating peritoneal sclerosis (EPS). The… 
Review
2005
Review
2005
Since the first peritoneal dialysis (PD) patients with encapsulating peritoneal sclerosis (EPS) were reported in 1980, EPS has… 
2003
2003
To investigate the role of adhesion molecules [intracellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1… 
2003
2003
Abstract:  Encapsulating peritoneal sclerosis (EPS) remains one of the major causes of dropout in continuous ambulatory… 
1996
1996
硬化性被嚢性腹膜炎 (sclerosing encapsulating peritonitis, SEP) はCAPD療法における最も重篤な合併症の1つである. 厚生省長期慢性疾患総合研究事業慢性腎不全研究班における 『CAPD…